共 11 条
[1]
Badawi Maha A, 2010, Adv Hematol, V2010, P164045, DOI 10.1155/2010/164045
[5]
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
[J].
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,
2012, 97 (09)
:1364-1371
[6]
Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes
[J].
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,
2010, 95 (08)
:1433-1434
[9]
Deferasirox is a powerful NF-κB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging
[J].
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,
2010, 95 (08)
:1308-1316